*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Bristol-Myers/NNP Co./NNP ]
and/CC 
[ Squibb/NNP Corp./NNP ]
said/VBD 
[ their/PRP$ stockholders/NNS ]
approved/VBD 
[ the/DT merger/NN ]
of/IN 
[ the/DT two/CD pharmaceutical/JJ firms/NNS ]
./. 

[ The/DT transaction/NN ]
thus/RB becomes/VBZ 
[ effective/JJ today/NN ]
,/, 
[ the/DT companies/NNS ]
said/VBD ./. 

======================================

[ Squibb/NNP ]
is/VBZ being/VBG merged/VBN into/IN 
[ Bristol-Myers/NNP ]
through/IN 
[ a/DT tax-free/JJ exchange/NN ]
of/IN 
[ 2.4/CD shares/NNS ]
of/IN 
[ Bristol-Myers/NNP common/JJ ]
for/IN 
[ each/DT Squibb/NNP common/JJ share/NN ]
outstanding/JJ ./. 

======================================

To/TO facilitate/VB 
[ the/DT merger/NN ]
,/, 
[ Bristol-Myers/NNP holders/NNS ]
also/RB voted/VBD to/TO double/VB 
[ the/DT authorized/JJ common/JJ ]
to/TO 
[ 1.5/CD billion/CD shares/NNS ]
./. 

[ The/DT company/NN ]
is/VBZ issuing/VBG 
[ 242/CD million/CD shares/NNS ]
in/IN 
[ connection/NN ]
with/IN 
[ the/DT merger/NN ]
./. 

[ Bristol-Myers/NNP ]
has/VBZ about/IN 
[ 288.1/CD million/CD shares/NNS ]
outstanding/JJ ./. 

======================================

[ The/DT new/JJ concern/NN ]
,/, to/TO be/VB known/VBN as/IN 
[ Bristol-Myers/NNP Squibb/NNP Co./NNP ]
and/CC based/VBN in/IN 
[ New/NNP York/NNP ]
,/, will/MD be/VB 
[ the/DT world/NN 's/POS second-largest/JJ pharmaceutical/JJ firm/NN ]
,/, 
[ the/DT companies/NNS ]
said/VBD ./. 

[ Richard/NNP L./NNP Gelb/NNP ]
,/, 
[ who/WP ]
has/VBZ been/VBN 
[ chairman/NN ]
and/CC 
[ chief/JJ executive/NN officer/NN ]
of/IN 
[ Bristol-Myers/NNP ]
,/, will/MD continue/VB in/IN 
[ those/DT capacities/NNS ]
./. 

[ Richard/NNP M./NNP Furlaud/NNP ]
,/, 
[ who/WP ]
has/VBZ been/VBN 
[ chairman/NN ]
and/CC 
[ chief/JJ executive/NN ]
of/IN 
[ Squibb/NNP ]
,/, will/MD be/VB 
[ president/NN ]
of/IN 
[ the/DT combined/VBN company/NN ]
with/IN 
[ designated/VBN responsibility/NN ]
for/IN 
[ its/PRP$ pharmaceutical/JJ business/NN ]
./. 
